Galimberti G, Ferrario D, Galimberti D, Galimberti RL, Giusti C, Rodríguez CF

Idioma: Español
Referencias bibliográficas: 33
Paginas: 99-108
Archivo PDF: 547.54 Kb.

RESUMEN

Los avances en la fototerapéutica de ciertas enfermedades dermatológicas crónicas, apuntan a encontrar nuevos sitios de acción a niveles moleculares con el menor daño de estructuras sin patología. La luz UVB a 308 nm. sobre la piel, produce un efecto inmunomodulador local, con disminución de los linfocitos T a nivel epidérmico y dérmico. Estos sistemas se sumarían a la batería terapéutica que dispone el dermatólogo para el tratamiento de ciertas dermatosis crónicas como: psoriasis, vitíligo, eccemas, alopecia areata, linfoma cutáneo (micosis fungoide, estadio 1A), liquen plano, etc. Las ventajas de los sistemas láser/lámpara de 308 nm. sobre las actuales modalidades terapéuticas en el tratamiento de ciertas dermatosis crónicas, son: la posibilidad del tratamiento selectivo de la piel afectada, con menor riesgo de efectos adversos sobre la piel sana circundante, aplicación de esquemas a altas dosis, lo que lleva a una rápida curación con una menor dosis acumulada. Presentamos la luz monocromática 308 nm. excimer excilite y sus avances en la utilización en dermatología.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Zanolli M. Phototherapy arsenal in the treatment of psoriasis. Dermatol Clin 2004; 22: 397-406.

2. Morison WL, Parrish JA, Block KJ. In vivo effect of UVB on lymphocyte function. Br J Dermatol 1979;101:513-9.

3. Takeshi Horio. Indication and action mechanisms of phototherapy. J Dermatol Sci 2000;23:17-21.

4. Toews GB, Bergstresser PR, Streilein JW. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follwing skin painting with DNFB. J Immunol 1980;124:445-53.

5. Lugar T A, Schwartz T A. Effects of UV light on cytokines and neuroendocrines hormones. Photoimmunology 1995:55-76.

6. Enk AH, Angeloni V, Vdey MC, Katz SI. Inhibi t ion of Langerhans cel ls antigen¡Ùpresenting function by IL-10: a role for IL-10 in induction of tolerance. J Immunol 1993;151 :2390-8.

7. Lugar TA. Immunomodulation by UV light; role of neuropeptides. Eur J Dermatol 1998;8: 198-9.

8. Chung HT, Burnham DK, Robertson B, Roberts LK, Daynes RA. Involvement of prostaglandins in the immune alterations caused by the exposure of mice to ultraviolet radiation. J Immunol 1986;137:2478-84.

9. Bianchi B, Campolmi P, Mavilia L, Danesi A, Rossi R, Cappugi P. Monochromatic excimer light (308 nm): an immunohistochemical study of cutaneous T cells and apoptosisrelated molecules in psoriasis. J Eur Acad Dermatol Venereol 2003;17:408.

10. Morelli JG, Kincannon J, Yohn JJ, Zekman T, Weston WL, Norris DA. Leukotrienes C4 and TNF-alpha are stimulators of human melanocyte migration in vitro. J Invest Dermatol 1992;98:290-5.

11. Cheryl Guttman. Lasers safely target areas of limited psoriatic lesions. Dermatology Times. Jul 1, 2004.

12. Spencer JM, Hadi SM. The excimer lasers. Drugs Dermatol 2004;3:522-5.

13. Bonis B, Kemeny L, Dobozy A, Bor Z, Szabo G, Ignacz F. 308 nm UVB excimer laser for psoriasis. Lancet 1997;350:1522.

14. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981;76:359-62.

15. Feldman SR, Mellen BG, Housman TS, Fitzpatrick RE, Geronemus RG, Friedman PM, Vasily DB et al. Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study. J Am Acad Dermatol 2002;46: 900¨C6.

16. Trehan M, Taylor CR. Medium-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 2002; 47:701¨C8.

17. Asawanonda P., Anderson R.R., Chang Y., Taylor C.R. 308-nm excimer laser for the treatment of psoriasis: a dose response study. Arch Dermatol 2000;136:619-24.

18. Aubin F, Vigan M, Puzenat E, Blanc D, Drobacheff C, Deprez P, Humbert P, Laurent R. Evaluation of a novel 308-nm monochromatic excimer light delivery system in dermatology: a pilot study in different chronic localized dermatoses Bri J Dermatol 2005;152:99¨C103.

19. Campolmi P, Mavilia L, Lotti R, Rossi R, Brazzini B, Hercogova J, Capuggi P. 308nm monochromatic excimer light for the treatment of palmoplantar psoriasis. Int J Immunopathol Pharmacol 2002; 11:11¨C3.

20. Kollner K, Wimmershoff MB, Hintz C, Landthaler M, Hohenleutner U. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis. Br J Dermatol. 2005;152:750-4.

21. Njoo MD, Westerhof W, Bos JD, Bossuyt PM. The development of guidelines for the treatment of vitiligo. Arch Dermatol 1999;135: 1514-21.

22. Passeron T, Ostovari N, Zakaria W, Fontas E, Larrouy JC, Lacour JP, Ortonne JP. Topical Tacrolimus and the 308-nm Excimer Laser. A Synergistic Combination for the Treatment of Vitiligo. Arch Dermatol. 2004;140:1065-9.

23. Gundogan C, Greve B, Raulin C. Treatment of alopecia areata with the 308-nm xenon chloride excimer laser: case report of two successful treatments with the excimer laser. Lasers Surg Med. 2004;34:86-90.

24. Trehan M, Taylor CR. Low-dose excimer 308-nm laser for the treatment of oral lichen planus. Arch Dermatol. 2004;140:415-20.

25. Duthie MS, Kimber I, Norval M. The effect of ultraviolet radiation on the immune system. Br J Dermatol 1999;140:995-1009.

26. Guckian M, Jones CD, Vestey JP, Cooper EJ, Dawe R, Gibbs NK, Nor val M. Immunomodulation at the initiation of phototherapy and photochemotherapy. Photodermatol Photoimmunol Photomed 1995;11:163-9.

27. Nistico S, Costanzo A, Saraceno R, Chimenti S. Effi cacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides. Br J Dermatol. 2004;151:877-9.

28. Mori M, Campolmi P, Mavilia L, Rossi R, Cappugi P, Pimpinelli N. J Am Acad Dermatol. 2004;50:943-5.

29. Warshaw E. N. Therapeutic options for chronic hand dermatitis. Dermatologic Therapy 2004,17:240¨C50.

30. Rosen K, Mobacken H, Swanbeck G. Chronic eczematous dermatitis of the hands: a comparison of PUVA and UVB treatment. Acta Derm Venereol 1987; 67: 48¨C54.

31. Simons JR, Bohnen IJ, van der Valk PG. A left¨Cright comparison of UVB phototherapy and topical photochemotherapy in bilateral chronic hand dermatitis after 6 weeks treatment. Clin Exp Dermatol 1997;22: 7¨C10.

32. Nordal EJ, Christensen OB. Treatment of chronic hand dermatoses with UVB-TL01. Acta Derm Venereol 2004;84:302-4.

33. Ozawa M, Ferenczi K, Kikuchi T, Cardinale I, Austin LM, Coven TR, Burack LH et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 1999;189: 711-8.